TOPIC

Big Pharma

Filter by:

Discover the latest product and capabilities announcements in Life Sciences as LNS Research highlights key insights from Veeva's R&D and Quality...

James Wells Oct 3, 2023

LNS Research Analyst Bob Francis gives his perspective on the Emerson-AspenTech merger, what opportunities and challenges it presents and the road...

Bob Francis Aug 18, 2022

Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX

Andrew Hughes Jun 1, 2021

As a member-level partner of LNS Research, you will receive our expert and proven Advisory Services. These exclusive benefits give your team:

Let us help you with key decisions based on our solid research methodology and vast industrial experience.

BOOK A STRATEGY CALL

Stay on top of the latest industrial transformation insights from our expert analysts